Cellebrite DI (CLBT) Net Cash Flow (2020 - 2025)

Cellebrite DI's Net Cash Flow history runs 6 years deep, the most recent figure standing at -$157.0 million for Q4 2025.

• On a quarterly basis, Net Cash Flow fell 376.59% year-over-year to -$157.0 million in Q4 2025; TTM through Dec 2025 was -$69.7 million, a 2179.81% decrease from a year earlier, with the FY2025 full-year figure at -$69.7 million, down 2179.81% from the prior year.
• Net Cash Flow fell to -$157.0 million in Q4 2025 per CLBT's latest filing, from $102.3 million in the prior quarter.
• Across five years, Net Cash Flow topped out at $102.3 million in Q3 2025 and bottomed at -$157.0 million in Q4 2025.
• The 5-year median for Net Cash Flow is $8.8 million (2021), against an average of -$426150.0.
• Across the five-year window, Net Cash Flow jumped 18040.49% in 2023 and slumped 696.71% in 2024, its largest moves.
• Year by year, Net Cash Flow stood at $36.2 million in 2021, then tumbled by 99.21% to $284000.0 in 2022, then soared by 18040.49% to $51.5 million in 2023, then climbed by 10.15% to $56.7 million in 2024, then plunged by 376.59% to -$157.0 million in 2025.
• Per Business Quant, the three latest CLBT Net Cash Flow figures stand at -$157.0 million (Q4 2025), $102.3 million (Q3 2025), and $87.0 million (Q2 2025).